Last 302.50 GBp
Change Today -5.00 / -1.63%
Volume 2.5K
As of 11:35 AM 09/1/14 All times are local (Market data is delayed by at least 15 minutes).

retroscreen virology grp plc (RVG) Snapshot

Open
302.50 GBp
Previous Close
307.50 GBp
Day High
302.50 GBp
Day Low
302.50 GBp
52 Week High
10/15/13 - 375.00 GBp
52 Week Low
12/13/13 - 252.00 GBp
Market Cap
165.5M
Average Volume 10 Days
462.8K
EPS TTM
0.03 GBp
Shares Outstanding
54.7M
EX-Date
--
P/E TM
94.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for RETROSCREEN VIROLOGY GRP PLC (RVG)

Related News

No related news articles were found.

retroscreen virology grp plc (RVG) Related Businessweek News

No Related Businessweek News Found

retroscreen virology grp plc (RVG) Details

Retroscreen Virology Group plc, a life sciences company, is engaged in the virology healthcare business in the United Kingdom. The company provides clinical services focused on the human challenge model (HCM) primarily to pharmaceutical companies and biotechnology organizations. It offers hVIVO, a technology platform that uses human challenge models to research disease and study new drugs in volunteers. The company develops the HCM for evidencing the efficacy of antiviral and viral therapeutics in respiratory syncytial virus, flu, and cold. Retroscreen Virology Group plc is based in London, the United Kingdom.

273 Employees
Last Reported Date: 04/17/14

retroscreen virology grp plc (RVG) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 261.0K GBP
Finance Director, Company Secretary and Direc...
Total Annual Compensation: 208.0K GBP
Compensation as of Fiscal Year 2013.

retroscreen virology grp plc (RVG) Key Developments

Retroscreen Virology Group Appoints Dr. Alison Fielding as Non-Executive Director

Retroscreen Virology Group plc announced that Dr. Alison Fielding has been appointed as a Non-Executive Director of the Company with immediate effect. Alison is Director of IP Impact at IP Group plc, a leading UK intellectual property commercialization company. She co-founded Techtran Group Limited and was the Chief Operating Officer of Techtran when it was acquired by IP Group in January 2005. She was a Director of IP Group from January 2005 to June 2013, promoted to Chief Technology officer in March 2007 and then Chief Operating Officer in May 2011.

Retroscreen Virology Group plc Announces Resignation of Charles Winward as Director

Retroscreen Virology Group plc announced that, as a consequence of stepping down from the Board of IP Group plc, Charles Winward has resigned as a Director of the Company and will leave the Board with immediate effect.

Retroscreen Virology Group plc Announces Board Changes

Retroscreen Virology Group plc announced further strategic changes to its Board of Directors (Board) as part of the ompany's ambitious growth strategy. Jaime Ellertson has been appointed as Non-Executive Chairman, with immediate effect, succeeding David Norwood, who will continue to play a pivotal role on the Board as a Non-Executive Director. Jaime Ellertson has a strong track record of leading fast growing, data and service driven companies through phases of rapid expansion, both in the private and public arena. Jaime is currently Chairman and Chief Executive Officer of Everbridge Inc. Jaime previously served as the Chief Executive Officer, President and Director of Gomez Inc. Jaime previously served as the Chief Executive Officer, President and Director of Gomez Inc. David Norwood was appointed Chairman of Retroscreen Virology Limited in February 2011 and became Chairman of the company in April 2012. David remains as a Non-Executive Director of the ompany, with a focus on the company's business growth and investor strategy.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RVG:LN 302.50 GBp -5.00

RVG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RVG.
View Industry Companies
 

Industry Analysis

RVG

Industry Average

Valuation RVG Industry Range
Price/Earnings 100.0x
Price/Sales 6.2x
Price/Book 3.9x
Price/Cash Flow 111.6x
TEV/Sales 6.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RETROSCREEN VIROLOGY GRP PLC, please visit www.retroscreen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.